65 I B, drugs, pharmaceuticals,&hematology related product FSS contract award

Ended Awarded Last action

Contract number
V797D60724
Awardee
Awarding agency
Task orders
1

Award facts

Opportunity
  • M5Q50A03 Solicitation number
Last date to order 100% complete
IDV ceiling
$7,700,450,460.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

This Federal Supply Schedule contract, awarded to Genentech USA, Inc., a foreign-owned biotechnology company, provides the U.S. Department of Veterans Affairs (VA) and other federal agencies access to a wide range of pharmaceutical products and services. The $7.7 billion contract has a period of performance through September 2023 and was established under the GSA's Pharmaceuticals and Drugs schedule.

Under this IDV, Genentech will supply critical medical products to support federal stockpiling, treatment, and emergency preparedness needs. This includes delivery orders like a $60 million award from the HHS Office of the Assistant Secretary for Preparedness and Response to acquire pharmaceuticals for the Strategic National Stockpile. Genentech also holds a $1 million Blanket Purchase Agreement with the VA to provide the spinal muscular atrophy treatment Evrysdi, helping the agency address specialized health needs of veterans. Genentech's extensive experience as a federal contractor enables it to efficiently fulfill diverse pharmaceutical requirements across the government through this and other IDV contract vehicles.

Task orders

IDV awards

IDV Agency Ceiling Awarded
36E79721A0011 BPA for evrysdi - base year with four one-year options National Acquisition Center (VA) $1,000,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00174 · Pharmaceuticals $0
Other Administrative Action P00173 · Administrative changes: correction MODP00133 $0
Supplemental Agreement for work within scope P00172 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00171 · 42-2A TPR. $0
Supplemental Agreement for work within scope P00169 $0
Supplemental Agreement for work within scope P00170 $0
Supplemental Agreement for work within scope P00168 $0
Supplemental Agreement for work within scope P00167 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00166 · 42-2A deletions $0
Supplemental Agreement for work within scope P00165 $0
Supplemental Agreement for work within scope P00164 $0
Supplemental Agreement for work within scope P00162 $0
Supplemental Agreement for work within scope P00163 $0
Supplemental Agreement for work within scope P00161 $0
Supplemental Agreement for work within scope P00160 $0
Supplemental Agreement for work within scope P00159 $0
Supplemental Agreement for work within scope P00158 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00157 · Admin product description change $0
Supplemental Agreement for work within scope P00156 · Temporary price reduction $0
Supplemental Agreement for work within scope P00155 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00154 · 42-2A OGA TPR. $0
Supplemental Agreement for work within scope P00150 $0
Supplemental Agreement for work within scope P00153 $0
Supplemental Agreement for work within scope P00151 $0
Supplemental Agreement for work within scope P00152 · 42-2A TPR. $0
Supplemental Agreement for work within scope P00149 $0
Supplemental Agreement for work within scope P00148 $0
Supplemental Agreement for work within scope P00147 $0
Supplemental Agreement for work within scope P00146 $0
Supplemental Agreement for work within scope P00144 $0
Supplemental Agreement for work within scope P00145 $0
Supplemental Agreement for work within scope P00143 $0
Supplemental Agreement for work within scope P00142 $0
Supplemental Agreement for work within scope P00141 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00140 · 65IB 42-2A VOL. TPR $0
Supplemental Agreement for work within scope P00139 $0
Supplemental Agreement for work within scope P00138 $0
Supplemental Agreement for work within scope P00136 $0
Supplemental Agreement for work within scope P00137 $0
Supplemental Agreement for work within scope P00135 $0
Supplemental Agreement for work within scope P00134 $0
Supplemental Agreement for work within scope P00133 $0
Supplemental Agreement for work within scope P00132 · Pharmaceuticals $0
Supplemental Agreement for work within scope P00131 $0
Supplemental Agreement for work within scope P00129 $0
Supplemental Agreement for work within scope P00130 $0
Supplemental Agreement for work within scope P00128 · Temporary price reduction $0
Supplemental Agreement for work within scope P00127 · 42-2A voluntary TPR $0
Supplemental Agreement for work within scope P00125 · 42-2A product addition. $0
Supplemental Agreement for work within scope P00126 · 65IB drugs, pharmaceuticals and hematology related products $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who was awarded contract V797D60724?

V797D60724 was awarded to Genentech Usa, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 30, 2016.

How much is contract V797D60724 worth?

V797D60724's own ceiling is $7,700,450,460.

How many orders have been placed under contract V797D60724?

1 order has been placed under V797D60724, the latest on September 14, 2022.

Who can order from contract V797D60724?

V797D60724 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract V797D60724 part of a contract vehicle?

Yes. V797D60724 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract V797D60724 competed?

The extent of competition for V797D60724 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV